** Robotic medical device maker's MYO.A shares soar 48% to
$5.66 premarket
** Company on Tuesday aftermarket said Centers for Medicare
& Medicaid Services (CMS) had authorized it to be a Medicare
provider urn:newsml:reuters.com:*:nBw5sw3vZa
** Designation enables Myomo to bill Medicare directly when
it delivers its MyoPro-powered orthosis, or brace, in 39 states
plus Washington D.C.
** Company's device supports the arm and restores function
in weakened or paralysed arms of patients suffering from stroke,
injury or neuromuscular disease
** Stock down ~58% this year, as of last close
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))